Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Apr;71(4):2810–2818. doi: 10.1128/jvi.71.4.2810-2818.1997

Inhibition of human T-cell leukemia virus type 2 Rex function by truncated forms of Rex encoded in alternatively spliced mRNAs.

V Ciminale 1, L Zotti 1, D M D'Agostino 1, L Chieco-Bianchi 1
PMCID: PMC191405  PMID: 9060636

Abstract

Three mRNA species encoding the x-III open reading frame are expressed in human T-cell leukemia virus type 2 (HTLV-2)-infected cells. An mRNA composed of exons 1, 2, and 3 produces the essential posttranscriptional regulator Rex; shorter 1-3 and 1-B mRNAs encode a family of x-III proteins of unknown function that represent truncated forms of Rex. This report presents an analysis of the functional interactions between Rex and the x-III proteins, results of which suggest a role for the x-III proteins as negative regulators of Rex function. Cotransfection assays demonstrated that the x-III proteins were able to inhibit the ability of Rex to activate the expression of a Rex-dependent mRNA. Analysis of intracellular compartmentalization in actinomycin D-treated cells showed that coexpression of the x-III proteins resulted in the sequestration of Rex into the nuclear compartment. Subcellular fractionation studies showed that Rex was preferentially localized in the cytoplasmic or nuclear fraction depending on its phosphorylation status and that coexpression of Rex with the x-III proteins changed the phosphorylation pattern of Rex and the intracellular distribution of the x-III proteins. In vitro protein binding assays demonstrated the formation of Rex-Rex homomultimeric complexes; however, mixed Rex/x-III multimers were not detected. These findings indicated a correlation between phosphorylation and intracellular trafficking of Rex and suggested that the mechanism underlying the inhibitory effects of the x-III proteins might result from an interference with these processes.

Full Text

The Full Text of this article is available as a PDF (971.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker A., Li X., Ruland C. T., Stephens D. W., Black A. C., Rosenblatt J. D. Human T-cell leukemia virus type 2 Rex inhibits pre-mRNA splicing in vitro at an early stage of spliceosome formation. J Virol. 1996 Aug;70(8):5511–5518. doi: 10.1128/jvi.70.8.5511-5518.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benko D. M., Robinson R., Solomin L., Mellini M., Felber B. K., Pavlakis G. N. Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting Rev-responsive element does not affect the fate of viral mRNA. New Biol. 1990 Dec;2(12):1111–1122. [PubMed] [Google Scholar]
  3. Berneman Z. N., Gartenhaus R. B., Reitz M. S., Jr, Blattner W. A., Manns A., Hanchard B., Ikehara O., Gallo R. C., Klotman M. E. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3005–3009. doi: 10.1073/pnas.89.7.3005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bhat N. K., Adachi Y., Samuel K. P., Derse D. HTLV-1 gene expression by defective proviruses in an infected T-cell line. Virology. 1993 Sep;196(1):15–24. doi: 10.1006/viro.1993.1450. [DOI] [PubMed] [Google Scholar]
  5. Black A. C., Chen I. S., Arrigo S., Ruland C. T., Allogiamento T., Chin E., Rosenblatt J. D. Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5'long terminal repeat. Virology. 1991 Apr;181(2):433–444. doi: 10.1016/0042-6822(91)90875-c. [DOI] [PubMed] [Google Scholar]
  6. Black A. C., Ruland C. T., Luo J., Bakker A., Fraser J. K., Rosenblatt J. D. Binding of nuclear proteins to HTLV-II cis-acting repressive sequence (CRS) RNA correlates with CRS function. Virology. 1994 Apr;200(1):29–41. doi: 10.1006/viro.1994.1159. [DOI] [PubMed] [Google Scholar]
  7. Black A. C., Ruland C. T., Yip M. T., Luo J., Tran B., Kalsi A., Quan E., Aboud M., Chen I. S., Rosenblatt J. D. Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure. J Virol. 1991 Dec;65(12):6645–6653. doi: 10.1128/jvi.65.12.6645-6653.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bogerd H. P., Fridell R. A., Madore S., Cullen B. R. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell. 1995 Aug 11;82(3):485–494. doi: 10.1016/0092-8674(95)90437-9. [DOI] [PubMed] [Google Scholar]
  9. Bogerd H. P., Huckaby G. L., Ahmed Y. F., Hanly S. M., Greene W. C. The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5704–5708. doi: 10.1073/pnas.88.13.5704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bogerd H., Greene W. C. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J Virol. 1993 May;67(5):2496–2502. doi: 10.1128/jvi.67.5.2496-2502.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Böhnlein S., Pirker F. P., Hofer L., Zimmermann K., Bachmayer H., Böhnlein E., Hauber J. Transdominant repressors for human T-cell leukemia virus type I rex and human immunodeficiency virus type 1 rev function. J Virol. 1991 Jan;65(1):81–88. doi: 10.1128/jvi.65.1.81-88.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cann A. J., Rosenblatt J. D., Wachsman W., Shah N. P., Chen I. S. Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature. 1985 Dec 12;318(6046):571–574. doi: 10.1038/318571a0. [DOI] [PubMed] [Google Scholar]
  13. Ciminale V., D'Agostino D. M., Zotti L., Chieco-Bianchi L. Coding potential of the X region of human T-cell leukemia/lymphotropic virus type II. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 (Suppl 1):S220–S227. doi: 10.1097/00042560-199600001-00033. [DOI] [PubMed] [Google Scholar]
  14. Ciminale V., D'Agostino D. M., Zotti L., Franchini G., Felber B. K., Chieco-Bianchi L. Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology. 1995 Jun 1;209(2):445–456. doi: 10.1006/viro.1995.1277. [DOI] [PubMed] [Google Scholar]
  15. Ciminale V., Pavlakis G. N., Derse D., Cunningham C. P., Felber B. K. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J Virol. 1992 Mar;66(3):1737–1745. doi: 10.1128/jvi.66.3.1737-1745.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cockerell G. L., Rovnak J., Green P. L., Chen I. S. A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo. Blood. 1996 Feb 1;87(3):1030–1035. [PubMed] [Google Scholar]
  17. D'Agostino D. M., Ciminale V., Pavlakis G. N., Chieco-Bianchi L. Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: involvement of continued rRNA synthesis in nuclear retention. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1063–1071. doi: 10.1089/aid.1995.11.1063. [DOI] [PubMed] [Google Scholar]
  18. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood. 1995 Nov 15;86(10):3619–3639. [PubMed] [Google Scholar]
  19. Gallay P., Swingler S., Aiken C., Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 1995 Feb 10;80(3):379–388. doi: 10.1016/0092-8674(95)90488-3. [DOI] [PubMed] [Google Scholar]
  20. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  21. Green P. L., Ross T. M., Chen I. S., Pettiford S. Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation. J Virol. 1995 Jan;69(1):387–394. doi: 10.1128/jvi.69.1.387-394.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Green P. L., Xie Y. M., Chen I. S. The Rex proteins of human T-cell leukemia virus type II differ by serine phosphorylation. J Virol. 1991 Jan;65(1):546–550. doi: 10.1128/jvi.65.1.546-550.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Green P. L., Xie Y. M., Chen I. S. The internal methionine codons of human T-cell leukemia virus type II rex gene are not required for p24rex production or virus replication and transformation. J Virol. 1990 Oct;64(10):4914–4921. doi: 10.1128/jvi.64.10.4914-4921.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Green P. L., Yip M. T., Xie Y., Chen I. S. Phosphorylation regulates RNA binding by the human T-cell leukemia virus Rex protein. J Virol. 1992 Jul;66(7):4325–4330. doi: 10.1128/jvi.66.7.4325-4330.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hope T. J., Bond B. L., McDonald D., Klein N. P., Parslow T. G. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J Virol. 1991 Nov;65(11):6001–6007. doi: 10.1128/jvi.65.11.6001-6007.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Katahira J., Ishizaki T., Sakai H., Adachi A., Yamamoto K., Shida H. Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding. J Virol. 1995 May;69(5):3125–3133. doi: 10.1128/jvi.69.5.3125-3133.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kestler H. W., 3rd, Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 1991 May 17;65(4):651–662. doi: 10.1016/0092-8674(91)90097-i. [DOI] [PubMed] [Google Scholar]
  28. Kim J. H., Kaufman P. A., Hanly S. M., Rimsky L. T., Greene W. C. Rex transregulation of human T-cell leukemia virus type II gene expression. J Virol. 1991 Jan;65(1):405–414. doi: 10.1128/jvi.65.1.405-414.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kubota S., Hatanaka M., Pomerantz R. J. Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein: alterations by coexpression of the HTLV-I p21x protein. Virology. 1996 Jun 15;220(2):502–507. doi: 10.1006/viro.1996.0339. [DOI] [PubMed] [Google Scholar]
  30. Mermer B., Felber B. K., Campbell M., Pavlakis G. N. Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res. 1990 Apr 25;18(8):2037–2044. doi: 10.1093/nar/18.8.2037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Meyer B. E., Malim M. H. The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 1994 Jul 1;8(13):1538–1547. doi: 10.1101/gad.8.13.1538. [DOI] [PubMed] [Google Scholar]
  32. Ohta M., Nyunoya H., Tanaka H., Okamoto T., Akagi T., Shimotohno K. Identification of a cis-regulatory element involved in accumulation of human T-cell leukemia virus type II genomic mRNA. J Virol. 1988 Dec;62(12):4445–4451. doi: 10.1128/jvi.62.12.4445-4451.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Orita S., Saiga A., Takagi S., Tanaka T., Okumura K., Aono Y., Hinuma Y., Igarashi H. A novel alternatively spliced viral mRNA transcribed in cells infected with human T cell leukemia virus type 1 is mainly responsible for expressing p21X protein. FEBS Lett. 1991 Dec 16;295(1-3):127–134. doi: 10.1016/0014-5793(91)81402-t. [DOI] [PubMed] [Google Scholar]
  34. Palmeri D., Malim M. H. The human T-cell leukemia virus type 1 posttranscriptional trans-activator Rex contains a nuclear export signal. J Virol. 1996 Sep;70(9):6442–6445. doi: 10.1128/jvi.70.9.6442-6445.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Richard N., Iacampo S., Cochrane A. HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm. Virology. 1994 Oct;204(1):123–131. doi: 10.1006/viro.1994.1516. [DOI] [PubMed] [Google Scholar]
  36. Rihs H. P., Peters R. Nuclear transport kinetics depend on phosphorylation-site-containing sequences flanking the karyophilic signal of the Simian virus 40 T-antigen. EMBO J. 1989 May;8(5):1479–1484. doi: 10.1002/j.1460-2075.1989.tb03531.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rimsky L., Dodon M. D., Dixon E. P., Greene W. C. Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator. Nature. 1989 Oct 5;341(6241):453–456. doi: 10.1038/341453a0. [DOI] [PubMed] [Google Scholar]
  38. Rimsky L., Hauber J., Dukovich M., Malim M. H., Langlois A., Cullen B. R., Greene W. C. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature. 1988 Oct 20;335(6192):738–740. doi: 10.1038/335738a0. [DOI] [PubMed] [Google Scholar]
  39. Rosenblatt J. D., Cann A. J., Slamon D. J., Smalberg I. S., Shah N. P., Fujii J., Wachsman W., Chen I. S. HTLV-II transactivation is regulated by the overlapping tax/rex nonstructural genes. Science. 1988 May 13;240(4854):916–919. doi: 10.1126/science.2834826. [DOI] [PubMed] [Google Scholar]
  40. Ross T. M., Pettiford S. M., Green P. L. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J Virol. 1996 Aug;70(8):5194–5202. doi: 10.1128/jvi.70.8.5194-5202.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sagata N., Yasunaga T., Ikawa Y. Two distinct polypeptides may be translated from a single spliced mRNA of the X genes of human T-cell leukemia and bovine leukemia viruses. FEBS Lett. 1985 Nov 11;192(1):37–42. doi: 10.1016/0014-5793(85)80038-7. [DOI] [PubMed] [Google Scholar]
  42. Schindler C., Shuai K., Prezioso V. R., Darnell J. E., Jr Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science. 1992 Aug 7;257(5071):809–813. doi: 10.1126/science.1496401. [DOI] [PubMed] [Google Scholar]
  43. Schwartz S., Felber B. K., Benko D. M., Fenyö E. M., Pavlakis G. N. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol. 1990 Jun;64(6):2519–2529. doi: 10.1128/jvi.64.6.2519-2529.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Schwartz S., Felber B. K., Pavlakis G. N. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol. 1992 Jan;66(1):150–159. doi: 10.1128/jvi.66.1.150-159.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Shima H., Takano M., Shimotohno K., Miwa M. Identification of p26Xb and p24Xb of human T-cell leukemia virus type II. FEBS Lett. 1986 Dec 15;209(2):289–294. doi: 10.1016/0014-5793(86)81129-2. [DOI] [PubMed] [Google Scholar]
  46. Shimotohno K., Miwa M., Slamon D. J., Chen I. S., Hoshino H., Takano M., Fujino M., Sugimura T. Identification of new gene products coded from X regions of human T-cell leukemia viruses. Proc Natl Acad Sci U S A. 1985 Jan;82(2):302–306. doi: 10.1073/pnas.82.2.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Siomi H., Shida H., Nam S. H., Nosaka T., Maki M., Hatanaka M. Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell. 1988 Oct 21;55(2):197–209. doi: 10.1016/0092-8674(88)90043-8. [DOI] [PubMed] [Google Scholar]
  48. Slamon D. J., Shimotohno K., Cline M. J., Golde D. W., Chen I. S. Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II. Science. 1984 Oct 5;226(4670):61–65. doi: 10.1126/science.6089351. [DOI] [PubMed] [Google Scholar]
  49. Solomin L., Felber B. K., Pavlakis G. N. Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of human immunodeficiency virus type 1. J Virol. 1990 Dec;64(12):6010–6017. doi: 10.1128/jvi.64.12.6010-6017.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Stauber R., Gaitanaris G. A., Pavlakis G. N. Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions: transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm. Virology. 1995 Nov 10;213(2):439–449. doi: 10.1006/viro.1995.0016. [DOI] [PubMed] [Google Scholar]
  51. Szilvay A. M., Brokstad K. A., Kopperud R., Haukenes G., Kalland K. H. Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. J Virol. 1995 Jun;69(6):3315–3323. doi: 10.1128/jvi.69.6.3315-3323.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wright C. M., Felber B. K., Paskalis H., Pavlakis G. N. Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science. 1986 Nov 21;234(4779):988–992. doi: 10.1126/science.3490693. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES